Clinical Trial Update: Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Chronic Systolic Heart Failure [Phase 3]

View source ↗

Summary

This update notes the termination of a Phase 3 trial evaluating udenafil therapy to improve symptoms, exercise tolerance, and hemodynamics in patients with chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systolic Heart Failure

Drugs mentioned

• udenafil (udenafil)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Systolic Heart Failure | Phase 3 | Status: TERMINATED